Gastroenteritis

Every August, gastrointestinal care providers and patient advocacy groups celebrate Gastroparesis Awareness Month, an annual campaign focused on improving understanding of gastroparesis and promoting preventive strategies.

Patients with acute gastroenteritis had up to fourfold increased odds for developing postinfection irritable bowel syndrome or functional dyspepsia, with a higher risk associated with proinflammatory microbes and SARS-CoV-2, data showed.

The FDA has approved Takeda Pharmaceuticals’ Eohilia as the “first and only oral therapy” for treatment of eosinophilic esophagitis in patients aged 11 years or older, according to a press release.

An acute gastroenteritis outbreak in late summer 2022 among hikers on the Pacific Crest Trail in Washington was likely caused by norovirus, according to a CDC investigation in Morbidity and Mortality Weekly Report.

Recent reports in the media and legal action have raised questions about the safety of popular weight-loss drugs, particularly about whether they increase the risk for events such as gastroparesis and gastroenteritis.

A personal injury law firm has filed a lawsuit against Novo Nordisk and Eli Lilly, alleging the manufacturers “downplayed the severity of the gastrointestinal events caused by Ozempic and Mounjaro,” such as gastroparesis and gastroenteritis.

The largest outbreak of acute gastroenteritis recorded in the Grand Canyon National Park backcountry occurred from April to June 2022 and affected at least 222 backpackers and rafters, data in Morbidity and Mortality Weekly Report showed.

In children with acute gastroenteritis, probiotics did not offer benefits, regardless of diarrhea timing or severity, according to a study published in the American Journal of Gastroenterology.